"From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV"

Project Information

BRAINVECTORS

Grant agreement ID: 286071

Project closed

Start date 1 November 2012

End date 31 October 2016

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 1 597 783,00

EU contribution € 1 597 783,00

Coordinated by

CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS
Switzerland